The Development and Impact of Anxiety With Migraines: A Narrative Review
- PMID: 35923673
- PMCID: PMC9339341
- DOI: 10.7759/cureus.26419
The Development and Impact of Anxiety With Migraines: A Narrative Review
Abstract
Migraine is a chronic, disabling neurological disorder characterized by recurrent episodes of headache. Psychiatric disorders have been reported to arise due to a patient's physical and emotional stress caused by migraine episodes, with anxiety disorders being one of the most commonly associated psychiatric disorder with migraine. This association poses the question of similar or shared pathogenesis between the two disorders and raises a concern for the diagnosis and management of situations when these disorders present together. In this review, we discuss the possible shared mechanism for the development of anxiety disorders in the presence of migraine, such as the vascular, nervous, and genetic factors that might hold the key to their association. We also discuss the number of clinical features shared by these conditions and provide evidence for the higher degree of association between these conditions. A focused evaluation of anxiety disorders in migraine might benefit patients with earlier diagnoses and improve their quality of life with effective pharmacotherapy and psychotherapy. This review also emphasizes the importance of preventing future migraine episodes with effective prophylactic medications to reduce the risk of developing anxiety disorders, and the need to discuss the medical and psychiatric management of anxiety disorders in patients suffering from migraines on an acute and long-term basis. .
Keywords: anxiety sensitivity; chronic migraine (cm); generalised anxiety disorder; migraine disorder; migraine headaches; migraine-type headache; mood and anxiety; ocd/ anxiety disorders; panic disorders; somatic symptoms of anxiety disorders.
Copyright © 2022, Kumar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
The Development of Psychiatric Illness and Chemoprophylaxis of Botulinum Toxin in Migraine: A Narrative Review.Cureus. 2022 Dec 27;14(12):e32998. doi: 10.7759/cureus.32998. eCollection 2022 Dec. Cureus. 2022. PMID: 36712737 Free PMC article. Review.
-
Role of Yoga as Adjunctive Therapy for Migraines: A Narrative Review of the Literature.Cureus. 2023 Nov 7;15(11):e48434. doi: 10.7759/cureus.48434. eCollection 2023 Nov. Cureus. 2023. PMID: 38073999 Free PMC article. Review.
-
Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion.Headache. 2020 Mar;60(3):526-541. doi: 10.1111/head.13709. Epub 2020 Jan 3. Headache. 2020. PMID: 31898813
-
Migraine headaches and mood/anxiety disorders in the ELSA Brazil.Headache. 2014 Sep;54(8):1310-9. doi: 10.1111/head.12397. Epub 2014 Jun 4. Headache. 2014. PMID: 24898830
-
Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification.Headache. 2010 Jan;50(1):32-41. doi: 10.1111/j.1526-4610.2009.01557.x. Epub 2009 Oct 21. Headache. 2010. PMID: 19845781
Cited by
-
Headache Characteristics and Risk Factors Among Healthcare Providers in Al-Ahsa, Saudi Arabia.Cureus. 2023 Sep 16;15(9):e45377. doi: 10.7759/cureus.45377. eCollection 2023 Sep. Cureus. 2023. PMID: 37849600 Free PMC article.
-
The Comprehensive Effect of Depression, Anxiety, and Headache on Pain Intensity and Painkiller Use in Patients with Headache Analyzed by Unsupervised Clustering Using Machine Learning.Biomedicines. 2025 May 30;13(6):1345. doi: 10.3390/biomedicines13061345. Biomedicines. 2025. PMID: 40564063 Free PMC article.
-
Alexithymia, Anger, Sensitivity to Mild Bodily Sensations and Personality Characteristics of Restless Legs Syndrome Patients: A Case-control Study.Turk Psikiyatri Derg. 2024;35(4):271-281. doi: 10.5080/u27472. Turk Psikiyatri Derg. 2024. PMID: 39783804 Free PMC article.
-
Anxiety Disorders, Anxious Symptomology and Related Behaviors Associated With Migraine: A Narrative Review of Prevalence and Impact.Curr Pain Headache Rep. 2025 Jan 29;29(1):40. doi: 10.1007/s11916-024-01312-9. Curr Pain Headache Rep. 2025. PMID: 39878907 Free PMC article. Review.
-
The Development of Psychiatric Illness and Chemoprophylaxis of Botulinum Toxin in Migraine: A Narrative Review.Cureus. 2022 Dec 27;14(12):e32998. doi: 10.7759/cureus.32998. eCollection 2022 Dec. Cureus. 2022. PMID: 36712737 Free PMC article. Review.
References
-
- Migraine. Silberstein SD. Lancet. 2004;363:381–391. - PubMed
-
- Migraine. Barnett R. Lancet. 2019;394:1897. - PubMed
-
- Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Vetvik KG, MacGregor EA. Lancet Neurol. 2017;16:76–87. - PubMed
-
- The pathophysiology of migraine: implications for clinical management. Charles A. Lancet Neurol. 2018;17:174–182. - PubMed
Publication types
LinkOut - more resources
Full Text Sources